| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $778K | +513.8% | +853.6% |
| Cost of Revenue | $488K | +626.7% | +6005.9% |
| Gross Profit | $290K | +386.6% | +294.1% |
| R&D Expense | $397K | +118.6% | +112.7% |
| SG&A Expense | $2.7M | +232.8% | +441.1% |
| Operating Income | -$4.2M | -86.9% | -122.6% |
| Pre-tax Income | -$4.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $915K | +5642.2% | — |
| Inventory | $468K | +29.2% | — |
| Current Assets | $3.5M | -52.4% | — |
| Total Assets | $7.4M | -30.8% | — |
| Current Liabilities | $9.0M | +28.0% | — |
| Total Liabilities | $9.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.2M | — | — |
| Capital Expenditures | $484K | — | — |
| Investing Cash Flow | -$1.4M | — | — |
| Financing Cash Flow | $10.3M | — | — |
| Free Cash Flow | -$8.7M | — | — |
| +85.4% |
| -58.6% |
| Net Income | -$4.2M | +85.4% | -58.6% |
| EPS (Basic) | -$0.15 | +92.5% | +31.8% |
| EPS (Diluted) | -$0.15 | +92.5% | +31.8% |
| +6.1% |
| — |
| Stockholders' Equity | -$2.1M | -221.8% | +90.2% |